New strategies for treatment of Candida vaginal infections

Walter Magliani, Stefania Conti, Antonella Salati, Simona Arseni, Raffaele Frazzi, Lara Ravanetti, Luciano Polonelli

Research output: Contribution to journalArticle

Abstract

New strategies for treatment of vaginal candidiasis have been recently exploited, due to widespread occurrence of this disease, in particular as recurrent infections, limitations of safe and efficacious antifungals as well as the lack of reliable preventative approaches. In this review new chemotherapeutic and immunotherapeutic strategies, based on the improved understanding of the immunopathogenesis of this prevalent human infection, will be discussed. The role of killer antibodies (or their molecular derivatives), i.e. antibodies that show antibiotic activity bearing the internal image of a yeast killer toxin (KT), characterized by a wide spectrum of microbicidal activity, and of the specific cell wall KT receptor as putative new therapeutic agents and preventative or therapeutic vaccines, respectively, will be particularly outlined.

Original languageEnglish
Pages (from-to)144-148
Number of pages5
JournalRevista Iberoamericana de Micologia
Volume19
Issue number3
Publication statusPublished - Sep 2002

Fingerprint

Candida
Yeast Killer Factor
Antibodies
Candidiasis
Infection
Cell Wall
Vaccines
Anti-Bacterial Agents
Therapeutics

Keywords

  • Anticandidal chemotherapy
  • Anticandidal immunotherapy
  • Anticandidal vaccines
  • Killer antibodies
  • Vaginal candidiasis

ASJC Scopus subject areas

  • Microbiology

Cite this

Magliani, W., Conti, S., Salati, A., Arseni, S., Frazzi, R., Ravanetti, L., & Polonelli, L. (2002). New strategies for treatment of Candida vaginal infections. Revista Iberoamericana de Micologia, 19(3), 144-148.

New strategies for treatment of Candida vaginal infections. / Magliani, Walter; Conti, Stefania; Salati, Antonella; Arseni, Simona; Frazzi, Raffaele; Ravanetti, Lara; Polonelli, Luciano.

In: Revista Iberoamericana de Micologia, Vol. 19, No. 3, 09.2002, p. 144-148.

Research output: Contribution to journalArticle

Magliani, W, Conti, S, Salati, A, Arseni, S, Frazzi, R, Ravanetti, L & Polonelli, L 2002, 'New strategies for treatment of Candida vaginal infections', Revista Iberoamericana de Micologia, vol. 19, no. 3, pp. 144-148.
Magliani W, Conti S, Salati A, Arseni S, Frazzi R, Ravanetti L et al. New strategies for treatment of Candida vaginal infections. Revista Iberoamericana de Micologia. 2002 Sep;19(3):144-148.
Magliani, Walter ; Conti, Stefania ; Salati, Antonella ; Arseni, Simona ; Frazzi, Raffaele ; Ravanetti, Lara ; Polonelli, Luciano. / New strategies for treatment of Candida vaginal infections. In: Revista Iberoamericana de Micologia. 2002 ; Vol. 19, No. 3. pp. 144-148.
@article{da923bc50ef0411d89744f74de44abdc,
title = "New strategies for treatment of Candida vaginal infections",
abstract = "New strategies for treatment of vaginal candidiasis have been recently exploited, due to widespread occurrence of this disease, in particular as recurrent infections, limitations of safe and efficacious antifungals as well as the lack of reliable preventative approaches. In this review new chemotherapeutic and immunotherapeutic strategies, based on the improved understanding of the immunopathogenesis of this prevalent human infection, will be discussed. The role of killer antibodies (or their molecular derivatives), i.e. antibodies that show antibiotic activity bearing the internal image of a yeast killer toxin (KT), characterized by a wide spectrum of microbicidal activity, and of the specific cell wall KT receptor as putative new therapeutic agents and preventative or therapeutic vaccines, respectively, will be particularly outlined.",
keywords = "Anticandidal chemotherapy, Anticandidal immunotherapy, Anticandidal vaccines, Killer antibodies, Vaginal candidiasis",
author = "Walter Magliani and Stefania Conti and Antonella Salati and Simona Arseni and Raffaele Frazzi and Lara Ravanetti and Luciano Polonelli",
year = "2002",
month = "9",
language = "English",
volume = "19",
pages = "144--148",
journal = "Revista Iberoamericana de Micologia",
issn = "1130-1406",
publisher = "Asociacion Espanola de Micologia",
number = "3",

}

TY - JOUR

T1 - New strategies for treatment of Candida vaginal infections

AU - Magliani, Walter

AU - Conti, Stefania

AU - Salati, Antonella

AU - Arseni, Simona

AU - Frazzi, Raffaele

AU - Ravanetti, Lara

AU - Polonelli, Luciano

PY - 2002/9

Y1 - 2002/9

N2 - New strategies for treatment of vaginal candidiasis have been recently exploited, due to widespread occurrence of this disease, in particular as recurrent infections, limitations of safe and efficacious antifungals as well as the lack of reliable preventative approaches. In this review new chemotherapeutic and immunotherapeutic strategies, based on the improved understanding of the immunopathogenesis of this prevalent human infection, will be discussed. The role of killer antibodies (or their molecular derivatives), i.e. antibodies that show antibiotic activity bearing the internal image of a yeast killer toxin (KT), characterized by a wide spectrum of microbicidal activity, and of the specific cell wall KT receptor as putative new therapeutic agents and preventative or therapeutic vaccines, respectively, will be particularly outlined.

AB - New strategies for treatment of vaginal candidiasis have been recently exploited, due to widespread occurrence of this disease, in particular as recurrent infections, limitations of safe and efficacious antifungals as well as the lack of reliable preventative approaches. In this review new chemotherapeutic and immunotherapeutic strategies, based on the improved understanding of the immunopathogenesis of this prevalent human infection, will be discussed. The role of killer antibodies (or their molecular derivatives), i.e. antibodies that show antibiotic activity bearing the internal image of a yeast killer toxin (KT), characterized by a wide spectrum of microbicidal activity, and of the specific cell wall KT receptor as putative new therapeutic agents and preventative or therapeutic vaccines, respectively, will be particularly outlined.

KW - Anticandidal chemotherapy

KW - Anticandidal immunotherapy

KW - Anticandidal vaccines

KW - Killer antibodies

KW - Vaginal candidiasis

UR - http://www.scopus.com/inward/record.url?scp=0036755486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036755486&partnerID=8YFLogxK

M3 - Article

C2 - 12825992

AN - SCOPUS:0036755486

VL - 19

SP - 144

EP - 148

JO - Revista Iberoamericana de Micologia

JF - Revista Iberoamericana de Micologia

SN - 1130-1406

IS - 3

ER -